Last month, Novartis announced that it will acquire Anthos Therapeutics, Inc., a Boston-based ... In 2024, Novartis acquired MorphoSys AG. The acquisition added pelabresib (late-stage BET ...

February is the shortest month, but there was still plenty of time for a rush of pharma and biotech hires, including a number ...

BOSTON -- The Boston University Terriers are Beanpot champs for the 32nd time in school history after beating rival Boston College, 4-1, in the title bout at TD Garden on Monday night. The ...

MorphoSys has said it will press ahead with regulatory filings for its myelofibrosis drug candidate pelabresib, despite mixed results in a phase 3 trial. The German biotech says it hopes the ...

Tatum's interior presence has been critical for Boston while Kristaps Porzingis works his way back from an illness.

© 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...

The biggest cancer-focused acquisition in 2024 was Novartis’ $2.9 billion purchase of MorphoSys. The deal, included the approved B-lymphocyte antigen CD19 inhibitor Monjuvi (tafasitamab ...

Openings: The Pearl launches a second location at Boston Landing (67 Guest St.), serving seafood and raw bar delights from owners Mika and Malik Winder. They opened their first location to acclaim ...

Garrett Crochet turned in his best performance since joining the Red Sox on Wednesday, mowing ...

MARLBOROUGH, Mass., Feb. 26, 2025 /PRNewswire/ -- Boston Scientific Corporation (the “Company”) (NYSE: BSX) today announced that American Medical Systems Europe B.V. (“AMS Europe”), its wholly owned ...